High-Purity (R)-2-((4-Aminophenethyl)amino)-1-phenylethanol Hydrochloride Manufacturer & Supplier - Quality Pharmaceutical Intermediate

Discover a premier source for (R)-2-((4-Aminophenethyl)amino)-1-phenylethanol Hydrochloride (CAS 521284-22-0), a vital chiral pharmaceutical intermediate crucial for the synthesis of Mirabegron. We are a leading manufacturer and supplier committed to providing exceptional quality and competitive pricing for your critical raw material needs.

Get a Quote & Sample

Key Advantages for Pharmaceutical Procurement

Superior Assay and Chiral Purity

Achieve consistent and high-quality Mirabegron production with an intermediate that guarantees an assay of ≥98.0% and chiral purity of ≥99.0%. This makes it an ideal choice for demanding pharmaceutical applications.

Secure Supply Chain from a Trusted Manufacturer

As a reputable manufacturer and supplier, we ensure a stable and reliable supply of (R)-2-((4-Aminophenethyl)amino)-1-phenylethanol Hydrochloride, minimizing risks to your production schedule.

Competitive Pricing for Bulk Purchases

We offer competitive pricing for (R)-2-((4-Aminophenethyl)amino)-1-phenylethanol Hydrochloride, making it an economically viable option for large-scale API manufacturing when you purchase directly from our facility.

Applications and Significance

Mirabegron Synthesis

This compound is a crucial intermediate in the multi-step synthesis of Mirabegron (CAS: 223673-61-8), a beta-3 adrenergic agonist used in treating overactive bladder.

Chiral Pharmaceutical Intermediates

Its high chiral purity makes it invaluable for stereoselective synthesis, a critical aspect in developing modern pharmaceuticals where specific enantiomers are required for efficacy and safety.

API Raw Material Sourcing

As a high-quality API raw material, it is sought after by pharmaceutical companies worldwide looking to streamline their manufacturing processes and ensure product integrity.

Laboratory Research and Development

Beyond large-scale production, this intermediate is also utilized in R&D settings for exploring new synthetic routes or developing related pharmaceutical compounds.